Richard B Lanman Selected Research

Cell-Free Nucleic Acids

1/2022	Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.
10/2020	Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study.
1/2020	Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer.
1/2020	Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors.
12/2019	Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.
10/2019	Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA.
10/2019	Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations.
9/2019	BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale.
8/2019	Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer.
1/2019	Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard B Lanman Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 01/2015
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2016
10	Lung Neoplasms (Lung Cancer) 01/2020 - 10/2016
8	Breast Neoplasms (Breast Cancer) 07/2021 - 10/2017
7	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 01/2018
6	Disease Progression 01/2020 - 10/2017
3	Carcinoma (Carcinomatosis) 10/2020 - 01/2017
3	Neoplasm Metastasis (Metastasis) 09/2020 - 11/2017
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2018
3	Adenocarcinoma of Lung 01/2020 - 09/2017
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2019
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 07/2017
2	Hypersensitivity (Allergy) 01/2020 - 12/2018
2	Adenocarcinoma 12/2019 - 01/2018
2	Microsatellite Instability 12/2019 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 10/2019 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2018
2	Thyroid Neoplasms (Thyroid Cancer) 01/2015 - 12/2013
2	Thyroid Nodule (Nodule, Thyroid) 01/2015 - 12/2010
2	Coronary Disease (Coronary Heart Disease) 07/2006 - 01/2006
1	Cholangiocarcinoma 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Appendiceal Neoplasms (Appendix Cancer) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2019
1	Dehydration (Water Stress) 10/2019
1	Nausea 10/2019
1	Fatigue 10/2019
1	Thrombocytopenia (Thrombopenia) 10/2019
1	Urogenital Neoplasms 01/2019
1	Turcot syndrome 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Peritoneal Neoplasms 08/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Neuroblastoma 01/2018

Drug/Important Bio-Agent (IBA)

41	Circulating Tumor DNAIBA 01/2022 - 01/2015
28	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2015
18	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2015
9	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2006
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 12/2018
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 12/2018
3	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2019
3	Phosphotransferases (Kinase)IBA 01/2020 - 01/2019
3	NucleotidesIBA 01/2020 - 01/2018
3	neratinibIBA 01/2020 - 10/2017
3	Biological ProductsIBA 12/2019 - 01/2018
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2018
2	HM781-36BIBA 03/2020 - 10/2019
2	ElectrolytesIBA 01/2020 - 10/2019
2	Neurofibromin 1 (Neurofibromin)IBA 01/2020 - 01/2019
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2020 - 01/2019
2	Estrogen ReceptorsIBA 01/2020 - 01/2019
2	alectinibIBA 11/2019 - 01/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
2	CrizotinibIBA 12/2018 - 11/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 12/2010
2	Anaplastic Lymphoma KinaseIBA 01/2018 - 01/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	PlatinumIBA 01/2021
1	pembrolizumabIBA 01/2020
1	AlpelisibIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Fulvestrant (Faslodex)FDA Link 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Isoleucine (L-Isoleucine)FDA Link 01/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2020
1	ras GTPase-Activating Proteins (ras-GAP)IBA 01/2020
1	Aromatase InhibitorsIBA 01/2020
1	Co-Repressor ProteinsIBA 01/2020
1	Pharmaceutical PreparationsIBA 10/2019
1	human ERBB2 proteinIBA 10/2019
1	Transaminases (Aminotransferases)IBA 10/2019
1	pertuzumabIBA 10/2019
1	taxaneIBA 10/2019
1	dabrafenibIBA 09/2019
1	trametinibIBA 09/2019
1	AfatinibIBA 01/2019
1	larotrectinibIBA 01/2019
1	osimertinibIBA 01/2019
1	palbociclibIBA 01/2019
1	CateninsIBA 01/2019
1	Pregnenolone Carbonitrile (PCN)IBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 01/2019
1	LigandsIBA 12/2018
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2018

Therapy/Procedure

27	Therapeutics 01/2022 - 01/2006
4	Precision Medicine 01/2020 - 01/2015
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2018
2	Immunotherapy 12/2019 - 06/2019
1	Castration 01/2019
1	Molecular Targeted Therapy 11/2018
1	Lymph Node Excision (Lymph Node Dissection) 01/2018